This has influenced clinical practice guidelines, leading to the broad adoption of an insulin basal-bolus regimen with a correctional scale as the standard of care for hyperglycemia in hospitalized patients [7, 9, 11]. The gene discussed is INS; the disease is Hyperglycemia.